ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 102,33
0,13%
Dow Jones
39 065,26
-1,53%
DAX
18 691,32
0,05%
Brent Oil
81,185
-0,42%
Bitcoin
67 558,38
-2,24%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. QuidelOrtho Corporation (QDEL)

  7. QuidelOrtho Corporation (QDEL) Actualités

QDEL

QuidelOrtho (QDEL)

QuidelOrtho Corporation
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:QDEL
DateHeureSourceTitreSymboleSociété
23/05/202413h00Business WireQuidelOrtho to Participate in 44th Annual William Blair Growth Stock ConferenceNASDAQ:QDELQuidelOrtho Corporation
21/05/202411h45PR Newswire (US)The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of June 11, 2024 in QuidelOrtho Corporation f/k/a Quidel Corporation Lawsuit - QDELNASDAQ:QDELQuidelOrtho Corporation
17/05/202422h21Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:QDELQuidelOrtho Corporation
17/05/202411h45PR Newswire (US)QuidelOrtho Corporation f/k/a Quidel Corporation Sued for Securities Law Violations - Contact The Gross Law Firm Before June 11, 2024 to Discuss Your Rights - QDELNASDAQ:QDELQuidelOrtho Corporation
15/05/202422h05Business WireQuidelOrtho Opens New Distribution Center in Pedricktown, NJNASDAQ:QDELQuidelOrtho Corporation
14/05/202411h45PR Newswire (US)The Gross Law Firm Notifies Shareholders of QuidelOrtho Corporation f/k/a Quidel Corporation(QDEL) of a Class Action Lawsuit and an Upcoming DeadlineNASDAQ:QDELQuidelOrtho Corporation
10/05/202411h45PR Newswire (US)Investors in QuidelOrtho Corporation f/k/a Quidel Corporation Should Contact The Gross Law Firm Before June 11, 2024 to Discuss Your Rights - QDELNASDAQ:QDELQuidelOrtho Corporation
08/05/202422h05Business WireQuidelOrtho Reports First Quarter 2024 Financial ResultsNASDAQ:QDELQuidelOrtho Corporation
07/05/202412h05PR Newswire (US)Investors who lost money on QuidelOrtho Corporation f/k/a Quidel Corporation (QDEL) should contact The Gross Law Firm about pending Class Action - QDELNASDAQ:QDELQuidelOrtho Corporation
03/05/202411h45PR Newswire (US)Class Action Filed Against QuidelOrtho Corporation f/k/a Quidel Corporation (QDEL) Seeking Recovery for Investors - Contact The Gross Law FirmNASDAQ:QDELQuidelOrtho Corporation
02/05/202414h00Business WireQuidelOrtho Appoints Brian J. Blaser as President and Chief Executive OfficerNASDAQ:QDELQuidelOrtho Corporation
26/04/202411h45PR Newswire (US)QuidelOrtho Corporation f/k/a Quidel Corporation Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - QDELNASDAQ:QDELQuidelOrtho Corporation
19/04/202412h40PR Newswire (US)Class Action Filed Against QuidelOrtho Corporation f/k/a Quidel Corporation (QDEL) - June 11, 2024 Deadline to Join - Contact The Gross Law FirmNASDAQ:QDELQuidelOrtho Corporation
17/04/202413h00Business WireQuidelOrtho To Report First Quarter 2024 Financial ResultsNASDAQ:QDELQuidelOrtho Corporation
10/04/202413h00Business WireQuidelOrtho Adds Fentanyl Test to Its Vitros® Systems as a MicroTip® Partnership AssayNASDAQ:QDELQuidelOrtho Corporation
02/04/202415h00Business WireQuidelOrtho Receives FDA 510(k) Clearance for Its QuickVue® COVID-19 TestNASDAQ:QDELQuidelOrtho Corporation
06/03/202422h35Business WireQuidelOrtho Receives Health Canada Approval for Quidel® Triage® PLGF Test for Laboratory Use in CanadaNASDAQ:QDELQuidelOrtho Corporation
29/02/202422h40Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:QDELQuidelOrtho Corporation
29/02/202421h29Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:QDELQuidelOrtho Corporation
26/02/202422h30Business WireQuidelOrtho to Participate in 45th Annual Raymond James Institutional Investor ConferenceNASDAQ:QDELQuidelOrtho Corporation
21/02/202413h30Business WireQuidelOrtho Announces Changes in Executive LeadershipNASDAQ:QDELQuidelOrtho Corporation
16/02/202422h08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:QDELQuidelOrtho Corporation
13/02/202422h05Business WireQuidelOrtho Reports Fourth Quarter and Full-Year 2023 Financial ResultsNASDAQ:QDELQuidelOrtho Corporation
23/01/202413h00Business WireQuidelOrtho to Report Fourth Quarter and Full-year 2023 Financial ResultsNASDAQ:QDELQuidelOrtho Corporation
22/12/202313h00Business WireQuidelOrtho to Present at 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:QDELQuidelOrtho Corporation
20/12/202322h05Business WireQuidelOrtho Receives 510(K) Clearance for Savanna® Multiplex Molecular Platform and Savanna® HSV 1+2/VZV PCR AssayNASDAQ:QDELQuidelOrtho Corporation
08/12/202322h14Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:QDELQuidelOrtho Corporation
16/11/202323h05Business WireQuidelOrtho to Participate in the Evercore ISI ConferenceNASDAQ:QDELQuidelOrtho Corporation
01/11/202321h05Business WireQuidelOrtho Reports Third Quarter 2023 Financial ResultsNASDAQ:QDELQuidelOrtho Corporation
17/10/202321h43PR Newswire (US)Powerful Lyme Disease Awareness PSA Featuring Christopher Meloni Illuminates Times SquareNASDAQ:QDELQuidelOrtho Corporation
 Showing the most relevant articles for your search:NASDAQ:QDEL

Dernières Valeurs Consultées

EU
IVBTC
VANECK VBTC INAV
BIT
P1UQ99
NLBNPIT1UQ99 20991231 2....
USOTC
CRLBF
Cresco Labs (QX)
EU
AUD5L
Amundi Finance Emissions...
EU
XS0212064231
Nedwbk 3 7485 34
NASDAQ
ADOCW
Edoc Acquisition
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés